Management of Duodenal Ulcer with Gastroesophageal Reflux Disease (GERD) with Intravenous Pantoprazole

Authors

  • Ari Fahrial Syam
  • Murdani Abdullah
  • Marcellus Simadibrata
  • Dadang Makmun
  • Chudahman Manan
  • Daldiyono Hardjodisasto

DOI:

https://doi.org/10.24871/41200326-28

Abstract

Proton pump inhibitors (PPIs) are the most effective anti secretory drugs available for controlling gastric acid acidity and volume. They are the drug of choice in the treatment for gastro esophageal reflux disease (GERD), Helicobacter pylori eradication, peptic ulcer and non steroidal anti-inflammatory drug (NSAID) gastropathy: For acute cases, an intravenous PPI is needed, especially for hospitalized patient. Recently, intravenous pantoprazole represents an alternative to intravenous histamine-2 receptor antagonists. We observed 2 patients who were treated with pantoprazole for duodenal ulcer, where one case had a complication of bleeding with a history of long term use of NSAID. After two weeks of treatment with pantoprazole, significant lesion healing from endoscopy findings was achieved in both cases. Keywords: peptic ulcer, upper gastrointestinal bleeding, proton pump inhibitors, pantoprazole
VOLUME 4, NUMBER 1, April 2003

Downloads

Published

2003-01-04

How to Cite

Syam, A. F., Abdullah, M., Simadibrata, M., Makmun, D., Manan, C., & Hardjodisasto, D. (2003). Management of Duodenal Ulcer with Gastroesophageal Reflux Disease (GERD) with Intravenous Pantoprazole. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, 4(1), 26–28. https://doi.org/10.24871/41200326-28

Issue

VOLUME 4, NUMBER 1, April 2003

Section

Case Reports

License

Authors who publish with this journal agree to the following terms:

a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).